Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
A Phase 1b/2, Open Label Umbrella Study Of Elranatamab (PF- 06863135), A B-Cell Maturation Antigen (BCMA) CD3 Bispecific Antibody, In Combination With Other Anti-Cancer Treatments In Participants With
Sponsored by Icon Clinical Research, Incorporated
Active
$1.2M Funding
4 People
External
Related Topics
cancer immunotherapy,
bispecific antibodies,
clinical trials,
bcma targeted therapy,
combination therapy
People
Sharad Khurana
Co-Investigator (COI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Ravitharan Krishnadasan
Co-Investigator (COI)
Medicine
﹒Clinical Professor, Medicine - (Clinical Series Track)
Krisstina Gowin
Principal Investigator (PI)
Medicine
﹒Associate Professor, Medicine - (Clinical Scholar Track)
Muhammad Husnain
Co-Investigator (COI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
